-- Announcement on Convening the 2025 Semi-annual Performance Briefing
Securities code: 603229 Securities abbreviation: Aoxiang Pharmaceutical Announcement number: 2025-038
Zhejiang Aoxiang Pharmaceutical Co., Ltd.
Announcement on Convening the 2025 Semi-annual Results Briefing Meeting
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Meeting time: September 9, 2025 (Tuesday) 15:00-16:00
Meeting location: Shanghai Stock Exchange Roadshow Center (Website: https://roadshow.sseinfo.com/)
Meeting method: Shanghai Securities Roadshow Center online interaction
Investors can log in to the homepage of the Shanghai Securities Roadshow Center website before 16:00 on September 2, 2025 (Tuesday) to September 8 (Monday), click on the "Question Pre-Solicitation" column, or ask questions through the company's email [email protected]. The company will answer questions of common concern to investors at the briefing.
Zhejiang Aoxiang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has released the company's 2025 semi-annual report on August 29, 2025. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's 2025 semi-annual operating results and financial status, the company plans to hold a 2025 semi-annual performance briefing on September 9, 2025 (Tuesday) 15:00-16:00 to communicate on issues of concern to investors.
1. Type of briefing session
This investor briefing will be held in an interactive online format. The company will interact and communicate with investors on the specific operating results and financial indicators for the first half of 2025, and answer questions of common concern to investors within the scope permitted by information disclosure.
2. Time and place of the briefing meeting
(1) Meeting time: September 9, 2025 (Tuesday) 15:00-16:00
(2) Meeting location: Shanghai Stock Exchange Roadshow Center (Website: https://roadshow.sseinfo.com/)
(3) Meeting method: Shanghai Securities Roadshow Center online interaction
3. Participants
Chairman and General Manager: Mr. Zheng Zhiguo
Secretary of the Board of Directors: Mr. Ying Xiaochen
Financial Director: Ms. Zhu Dingmin
Independent Director: Mr. Luo Mingmin
4. How to participate as an investor
(1) Investors can log in to the SSE Roadshow Center (https://roadshow.sseinfo.com/) through the Internet at 15:00-16:00 on September 9, 2025 (Tuesday) to participate in this performance briefing online. The company will answer investors' questions in a timely manner.
(2) Investors can log in to the homepage of the SSE Roadshow Center website from September 2, 2025 (Tuesday) to September 8 (Monday) before 16:00, click on the "Ask a Question Pre-Solicitation" column (https://roadshow.sseinfo.com/preCallQa), and select this event according to the event time or via the company's email [email protected] Ask the company questions and the company will answer questions of common concern to investors at the briefing.
5. Contact person and consultation method
Contact Department: Board Office
Contact person: Wang Tuantuan
Tel: 0576-85589367
Email: [email protected]
6. Other matters
After this investor briefing is held, investors can check the status and main content of this investor briefing through the SSE Roadshow Center (https://roadshow.sseinfo.com/).
Announcement is hereby made.
Board of Directors of Zhejiang Aoxiang Pharmaceutical Co., Ltd.
August 29, 2025